5/24/2013

The FDA has cleared Roche to market its Cobas Integra 800 Tina-quant HbA1cDx assay for use in diabetes detection. The laboratory assay is said to be the first such device to be granted marketing clearance for measuring blood-glucose control as well as diagnosing diabetes accurately.

Related Summaries